Companies: 10,636     total market cap: NZ$234.502 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Alnylam Pharmaceuticals
ALNY
#366
Rank
NZ$106.60 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$806.95
Share price
-1.68%
Change (1 day)
85.55%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: NZ$106.60 Billion

As of December 2025 Alnylam Pharmaceuticals has a market cap of NZ$106.60 Billion. This makes Alnylam Pharmaceuticals the world's 366th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$106.60 B95.89%
2024NZ$54.42 B43.28%
2023NZ$37.98 B-17.52%
2022NZ$46.05 B55.09%
2021NZ$29.69 B41.89%
2020NZ$20.92 B9.08%
2019NZ$19.18 B74.45%
2018NZ$10.99 B-38.01%
2017NZ$17.74 B282.49%
2016NZ$4.63 B-60.37%
2015NZ$11.70 B22.46%
2014NZ$9.55 B91.63%
2013NZ$4.98 B328.31%
2012NZ$1.16 B160.99%
2011NZ$0.44 B-17.55%
2010NZ$0.54 B-46.68%
2009NZ$1.01 B-42.49%
2008NZ$1.76 B14.01%
2007NZ$1.54 B37.54%
2006NZ$1.12 B198.59%
2005NZ$0.37 B86.71%
2004NZ$0.20 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

NZ$106.60 Billion
by Nasdaq info icon info icon
NZ$106.60 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Arrowhead Pharmaceuticals
ARWR
NZ$15.50 B-85.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$132.84 B 24.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$4.14 B-96.11%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ$1.85 B-98.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$0.97 B-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$440.64 B 313.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$206.98 B 94.15%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
NZ$56.52 B-46.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com